Axsome Therapeutics - An update on Progress

This will be an important year for Axsome Therapeutics, as they transform from a pure drug development company, to a drug development plus commercialization company. Below are some projected timelines that the company is planning on achieving for the first half of 2021.

• AXS-05 for MDD, new drug application to be accepted by the FDA mid April.
• AXS-07 for acute migraine, new drug application to be filed in April.
• AXS-07 new drug application to be accepted by the FDA in June.
• AXS-12 starts Phase 3 for narcolepsy in the second quarter.

                         

The weekly chart above illustrates that axsm has been trading in a range for the past ten months. As it currently stands today, the stock is at the lower bounds of the range making it a lower risk entry, for those looking to invest in the company.                               

 

Bitcoin - Cryptocurrency

Cryptocurrency's such as Bitcoin are just starting to make their way mainstream, due to corporations, banks, online payment, and credit card companies looking for a decentralized alternative to fiat money. Bitcoin is seen as a more superior reserve asset, and store of value than the U.S. dollar or gold. To preserve our purchasing power due to the potential for run-away inflation, along with an increasing monetary supply, converting cash into a digital currency such as Bitcoin can be appealing. If we look at long-term vehicles to park our cash as a comparison, there is little incentive for buying bonds, as yields on a ten year basis is less than 1.50% annual. Looking for a web site to stay up to date, and learn more about cryptocurrency, Cointelegraph is a quality site to explore. Below is a list of sectors that have recently adopted Bitcoin.

• Online payment - PayPal
• Corporations - MicroStrategy, Tesla
• Credit Card - Mastercard
• Insurance - Mass Mutual
• Bank - BNY Mellon

Below is a daily chart of Bitcoin, which has broken out to new all-time highs, above $50,000, just this week. Thank you for reading.